| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 09/16/2004 | WO2004055199A3 A biological sample storage device and method for biological sample contamination testing |
| 09/16/2004 | WO2004055037A3 Process for purifying oligonucleotide synthons |
| 09/16/2004 | WO2004027080A3 Method of extracting nucleic acids from microbial samples |
| 09/16/2004 | WO2003087053A3 Reagent and process for protecting nucleoside active groups |
| 09/16/2004 | WO2003073989A3 Nucleoside 5'-monophosphate mimics and their prodrugs |
| 09/16/2004 | WO2002068537A3 Fluorescent dye |
| 09/16/2004 | US20040181078 Chemical Intermediates for tetraphosphonate bicyclic trisanhydrideswith sulfur groups or nitrogen groups |
| 09/16/2004 | US20040181063 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 09/16/2004 | US20040181052 Process for the production of pentostatin aglycone and pentostatin |
| 09/16/2004 | US20040181051 Selectively esterifying 3' hydroxyl position of a 2'-branched ribofuranosyl nucleoside to generate viricide for prevention of flaviviral infection |
| 09/16/2004 | US20040180909 Method for producing mixed crystal of disodium 5'-guanylate and disodium 5'-inosinate |
| 09/16/2004 | US20040180908 (2S,3S,4R,5R)-2-(5-tert-Butyl-[1,3,4]-oxadiazol-2-yl)-5-[6-(4-chloro-2-fluorophenylamino)-9H-purin-9-yl]-tetrahydrofuran-3,4-diol |
| 09/16/2004 | CA2517674A1 Process for preparing dideoxyinosine using adenosine deaminase enzyme |
| 09/16/2004 | CA2517017A1 Methods for detection of genetic disorders |
| 09/16/2004 | CA2516677A1 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/15/2004 | EP1457495A1 Adenosine A1 receptor agonists |
| 09/15/2004 | EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 09/15/2004 | EP1456218A2 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position |
| 09/15/2004 | EP1455799A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
| 09/15/2004 | EP1032708A4 Nucleic acid ligands of tissue target |
| 09/15/2004 | CN1528774A Improved method for preparing anti-parasite preparation |
| 09/15/2004 | CN1166678C Purine derivatives |
| 09/15/2004 | CN1166677C Thiophene A2A receptor aganoists |
| 09/15/2004 | CN1166651C Anti-inflammatory and antineoplastic R-bis or glycophenylpropane isoselenazole substituted compound |
| 09/14/2004 | US6790836 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 09/14/2004 | CA2088258C Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression |
| 09/10/2004 | WO2004076472A1 Novel guanosine derivatives and use thereof |
| 09/10/2004 | WO2004058393A3 Method for the validated construction of arrays |
| 09/09/2004 | US20040176587 Process for the preparation of l-ribavirin |
| 09/09/2004 | US20040176570 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 09/09/2004 | US20040175804 Process for preparing dideoxyinosine using adenosine deaminase enzyme |
| 09/09/2004 | US20040175741 comprises novel photolabile protective groups, which provide faster deprotection times and enhanced conversion rates for nucleosidic and nucleotidic derivatives while producing lower levels of side products |
| 09/09/2004 | US20040175726 Compounds for protecting hydroxyls and methods for their use |
| 09/08/2004 | EP1453848A2 Sir2 products and activities |
| 09/08/2004 | EP1453602A2 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences |
| 09/08/2004 | EP1324761A4 Uridine therapy for patients with elevated purine levels |
| 09/08/2004 | EP1292313B1 Methods for treating hepatitis delta virus infection with beta-l-2' deoxy-nucleosides |
| 09/08/2004 | EP1140933B1 Process for preparing n6-substituted deaza-adenosine derivatives |
| 09/08/2004 | EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules |
| 09/08/2004 | CN1527837A Method for producing mixed crystal of disodium 5'-guanylate and disodium 5'-inosinate |
| 09/08/2004 | CN1527836A Antiviral agents for treatment of flaviviridae infections |
| 09/08/2004 | CN1526719A Deoxyoligonucleotide containing CpG single strand for strengthening immunological effect of Protein vaccine |
| 09/08/2004 | CN1526718A Antivira and antitumor deoxyoligonucleotide containing CpG single strand |
| 09/08/2004 | CN1526711A Synthesis process of important intermediate for anticancer medicine Gemcitabine |
| 09/07/2004 | US6787526 Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
| 09/07/2004 | US6787525 Method of treating hiv infections and/or cancer diseases |
| 09/02/2004 | WO2004074503A2 Nucleic acid sequencing methods, kits and reagents |
| 09/02/2004 | WO2004074300A2 Novel photolabile protective groups for improved processes to prepare oligonucleotide arrays |
| 09/02/2004 | WO2004045371A3 Methods for diagnosing the presence or stage of cancer |
| 09/02/2004 | WO2003000200A3 β-2'-OR 3'-HALONUCLEOSIDES |
| 09/02/2004 | US20040171820 To be used in hybridization methods, for the determination of a nucleic acid |
| 09/02/2004 | US20040171676 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 09/02/2004 | US20040171578 in particular of inflammatory and hyperproliferative skin diseases, and cutaneous manifestations of immunologically induced diseases |
| 09/02/2004 | US20040171577 Aryl phosphate derivatives of d4T having anti-HIV activity |
| 09/02/2004 | US20040171124 includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers; effective against human immunodeficiency virus (HIV), hepatitis B virus (HBV), and other viruses |
| 09/02/2004 | US20040171040 Detectable labeled nucleoside analogs and methods of use thereof |
| 09/01/2004 | EP1452604A2 Coenzyme useful for the synthesis of L-Carnitine |
| 09/01/2004 | EP1451365A2 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 09/01/2004 | EP1451351A2 Labelled nucleotides |
| 09/01/2004 | EP1451203A1 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimine nucleosides and uses thereof |
| 09/01/2004 | EP1451202A1 Aryl fused azapolycyclic compounds |
| 09/01/2004 | EP1451201A2 Nucleotide analogues and their use for nucleic acid sequencing |
| 09/01/2004 | EP1451178A1 Processes for preparing beta-d-ribofuranose derivatives |
| 09/01/2004 | EP1450798A1 Use of an ascomycin for the treatment of blepharitis |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 08/31/2004 | US6784166 For the treatment of diseases mediated by the hepatitis c virus |
| 08/31/2004 | US6784161 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/26/2004 | WO2004072297A2 Terminal-phosphate-labeled nucleotides and methods of use |
| 08/26/2004 | WO2004072234A2 Protection of nucleosides |
| 08/26/2004 | WO2004072090A1 Process for preparing branched ribonucleosides from 1, 2-anhydroribofuranose intermediates |
| 08/26/2004 | WO2004058392A3 Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups |
| 08/26/2004 | WO2004058391A3 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
| 08/26/2004 | WO2004019002A3 Fluorescent glycosides and methods for their use |
| 08/26/2004 | WO2004016755A3 Amplification of target nucleotide sequence without polymerase chain reaction |
| 08/26/2004 | US20040167140 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/26/2004 | US20040167096 Using a dideoxy and didehydro nucleoside |
| 08/26/2004 | US20040167092 Medicaments |
| 08/26/2004 | US20040166529 Comprises electrophoretic tag (e-tag) probes for the multiplexed detection of binding or interactions between one or more ligands and target antiligands; biomolecular marker and signal resolution |
| 08/26/2004 | CA2513672A1 Terminal-phosphate-labeled nucleotides and methods of use |
| 08/25/2004 | EP1448579A1 Phospholipid derivatives of nucleosides as antitumoral medicaments |
| 08/25/2004 | EP0755458B1 Electrogenerated chemiluminescence labels for analysis and/or referencing |
| 08/25/2004 | CN1522994A Use of plant extract of anoectochilus formosanus and fraction originating from the same as galenicals or dietary supplement for chemical defense or treatment of human malignant lesion |
| 08/25/2004 | CN1163502C Novel A1 adenosine receptor incitant |
| 08/24/2004 | US6781001 Extended rhodamine dye compound suitable for the creating of sets of spactrally resolvable fluorescent labels particlularly useful for fluorescence based dna sequencing system |
| 08/24/2004 | US6780988 Processes for producing P1,P4-diuridine-5′-tetraphosphate |
| 08/24/2004 | US6780616 By cultivation of streptomyces |
| 08/24/2004 | CA2347336C A1 adenosine receptor agonists |
| 08/19/2004 | WO2004070052A2 Compounds and processes for single-pot attachment of a label to nucleic acid |
| 08/19/2004 | WO2004069856A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069261A1 Process for producing antiherpesvirus preparation for external use |
| 08/19/2004 | WO2004069171A2 Novel compounds for the treatment of sickle cell disease |
| 08/19/2004 | WO2004050678A3 Compounds resistant to metabolic deactivation and methods of use |
| 08/19/2004 | WO2004016805A9 Immunostimulatory nucleic acids |
| 08/19/2004 | WO2003006625A8 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 08/19/2004 | US20040162424 Method of producing derivatives of lactosamine |
| 08/19/2004 | US20040162422 adenosine derivatives having an acetylene group in the 4' position, which are adenosine A1 agonists; treating ischaemic heart disease, peripheral vascular disease or stroke or patient suffering pain, a CNS disorder, sleep apnoea or emesis |
| 08/19/2004 | US20040162297 For manufacture of a medicament for use in decreasing plasma free fatty acid concentration; reducing heart rate; or treating ischemic heart disease, peripheral vascular disease, stroke, pain, CNS disorder, or sleep apnoea |
| 08/19/2004 | US20040162265 Polymorphism crystal structure; stability |